B. Résultats-principaux and .. , 24 1. Description de la population, p.24

. Akkaya, Neurolytic phenol blockade of the obturator nerve for severe adductor spasticity, Acta Anaesthesiologica Scandinavica, vol.54, issue.1, pp.79-85, 2010.
DOI : 10.1111/j.1399-6576.2009.02130.x

. Angel, The H reflex in normal, spastic and rigid subjets, Arch Neurol, vol.9, pp.591-597, 1963.

. Arroyo, Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study, International Journal of Neuroscience, vol.13, issue.2, 2013.
DOI : 10.1016/S1474-4422(05)70166-6

. Aymard, Presynaptic inhibition and homosynaptic depression: A comparison between lower and upper limbs in normal human subjects and patients with hemiplegia, Brain, vol.123, issue.8
DOI : 10.1093/brain/123.8.1688

. Barnes, Spasticity in Multiple Sclerosis, Neurorehabilitation and Neural Repair, vol.46, issue.9, 2003.
DOI : 10.1212/WNL.33.11.1444

. Barnes, Efficacy and safety of NT???201 for upper limb spasticity of various etiologies - a randomized parallel-group study, Acta Neurologica Scandinavica, vol.87, issue.4, pp.295-302, 2010.
DOI : 10.1111/j.1600-0404.2010.01354.x

. Bennett, Evidence for plateau potentials in tail motoneurons of awake chronic spinal rats with spasticity, J Neurophysiol, vol.86, issue.4, pp.1972-82, 2001.

. Bensmail, Botulinum toxin and spinal cord injury Annales de réadaptation et de médecine physique, pp.296-298, 2003.

. Bensmail, Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients, Mult Scler. Feb, vol.12, issue.1, pp.101-104, 2006.

. Bensmail, Epidemiology and multiple assessment of spasticity in multiple sclerosis

. Borg, Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: Evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity, Journal of Rehabilitation Medicine, vol.43, issue.1, pp.15-22, 2011.
DOI : 10.2340/16501977-0663

. Borrini, ??v??nements ind??sirables lors de l???infusion intrath??cale chronique de baclof??ne??: ??tude descriptive d???une cohorte de 158??patients suivis durant une ann??e, ou Annals of Physical and Rehabilitation Medicine, 2012.
DOI : 10.1016/j.rehab.2012.07.838

URL : http://doi.org/10.1016/j.rehab.2012.07.838

. Brar, Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis, Arch Phys Med Rehabil, vol.72, issue.3, pp.186-195, 1991.

. Brashear, Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke, New England Journal of Medicine, vol.347, issue.6, pp.395-400, 2002.
DOI : 10.1056/NEJMoa011892

. Cardoso, Botulinum Toxin Type A for the Treatment of the Spastic Equinus Foot in Cerebral Palsy, Pediatric Neurology, vol.34, issue.2, pp.106-115, 2006.
DOI : 10.1016/j.pediatrneurol.2005.08.010

. Crone, Disynaptic reciprocal inhibition of ankle extensors in spastic patients, Brain, vol.117, issue.5, pp.1161-1169, 1994.
DOI : 10.1093/brain/117.5.1161

. Cutter, Gabapentin effect on spasticity in multiple sclerosis: A placebo-controlled, randomized trial, Archives of Physical Medicine and Rehabilitation, vol.81, issue.2, pp.164-173, 2000.
DOI : 10.1016/S0003-9993(00)90135-7

. Dalgas, Resistance training improves muscle strength and functional capacity in multiple sclerosis, Neurology, vol.73, issue.18, pp.1478-84, 2009.
DOI : 10.1212/WNL.0b013e3181bf98b4

. Debouverie, Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France, Multiple Sclerosis Journal, vol.109, issue.1, pp.962-967, 2007.
DOI : 10.1002/ana.410130302

. Decq, Les neurotomies périphériques dans le traitement de la spasticité focale des membres, Neurochirurgie, vol.49, issue.2-3, pp.293-305, 2003.

. Deffontaines-rufin, Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients, International braz j urol, vol.37, issue.5, pp.642-650, 2011.
DOI : 10.1590/S1677-55382011000500012

. Delwaide, Clinical neurophysiology of tendon hyperreflexia, Bull Acad R Med Belg, vol.128, issue.3, pp.271-93, 1973.

. Denormandie, Les traitements orthopédiques des conséquences de la spasticité au membre inférieur, Neurochirurgie, vol.49, pp.339-352, 2003.

. Elovic, Repeated Treatments With Botulinum Toxin Type A Produce Sustained Decreases in the Limitations Associated With Focal Upper-Limb Poststroke Spasticity for Caregivers and Patients, Archives of Physical Medicine and Rehabilitation, vol.89, issue.5, pp.799-806, 2008.
DOI : 10.1016/j.apmr.2008.01.007

A. Esquenazi, Improvements in healthcare and cost benefits associated with botulinum toxin treatment of spasticity and muscle overactivity, European Journal of Neurology, vol.20, issue.2, pp.27-34, 2006.
DOI : 10.1080/16501970510027312

. Gallien, Place de la toxine botulique dans le traitement de la spasticité dans la sclérose en plaques. Annals of physical and rehabilitation medecine, 2012.

. Gallien, Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.12, pp.1670-1676, 2005.
DOI : 10.1136/jnnp.2004.045765

URL : https://hal.archives-ouvertes.fr/hal-00272273

. Gill, Combined treatment with BTX-A and ITB for spasticity: case report

. Gracies, Evaluation de la spasticité, apport de l'échelle de Tardieu, Motricité cérébrale, vol.22, pp.1-16, 2001.

. Gracies, Pathophysiology of spastic paresis. I: Paresis and soft tissue changes, Muscle & Nerve, vol.89, issue.5, pp.535-51, 2005.
DOI : 10.1002/mus.20284

. Gracies, Pathophysiology of spastic paresis. II: Emergence of muscle overactivity, Muscle & Nerve, vol.89, issue.5, pp.552-71, 2005.
DOI : 10.1002/mus.20285

. Gracies, Contrat d'autorééducation guidée dans la parésie spastique Bibliothèque nationale: juin 2013, pp.978-35327

. Grauwin, Quelle stratégie pour les dystonies du long extenseur de l'hallux et celle du long extenseur des orteils ? Annals of Physical and Rehabilitation Medicine, pp.390-391, 2013.

. Hyman, Botulinum toxin (Dysport(R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study, Journal of Neurology, Neurosurgery & Psychiatry, vol.68, issue.6
DOI : 10.1136/jnnp.68.6.707

F. Jerusalem, Double-blind study on the antispastic effect of beta-94-chlorphenyl-gamma aminobutyric acid (CIBA) in multiple sclerosis, Nervenarzt, vol.39, pp.515-522, 1968.

. Kalsi, Botulinum injections for the treatment of bladder symptoms of multiple sclerosis, Annals of Neurology, vol.47, issue.5, pp.452-459, 2007.
DOI : 10.1002/ana.21209

. Katz, Recurrent inhibition in humans, Progress in Neurobiology, vol.57, issue.3, pp.325-55, 1999.
DOI : 10.1016/S0301-0082(98)00056-2

. Khan, Multidisciplinary rehabilitation for adults with multiple sclerosis

. Kobelt, Costs and quality of life of patients with multiple sclerosis in Europe, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.8
DOI : 10.1136/jnnp.2006.090365

. Lance, Symposium Synopsis. Spasticity: disordered motor control Chicago. Year Book Medical Publishers, 1980.

. Lamotte, Multiple sclerosis and botulinum toxin Annales de réadaptation et de medicine physique 2003, pp.299-302

. Lennerstrand, Treatment of strabismus and nystagmus with botulinum toxin type A, An evaluation of effects and complications, Acta Ophthalmologica Scandinavica, vol.76, issue.1, pp.27-34, 1998.
DOI : 10.1034/j.1600-0420.1998.760106.x

. Mailhan, Non-medicinal treatments of spasticity in multiple sclerosis, Rev. Neurol, vol.168, pp.36-44, 2012.

. Marque, Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.1, pp.36-42, 2001.
DOI : 10.1136/jnnp.70.1.36

. Marque, Physiopathologie de la spasticit??, Revue Neurologique, vol.168, pp.36-44
DOI : 10.1016/S0035-3787(12)70045-0

. Mehnert, The Effect of Botulinum Toxin Type A on Overactive Bladder Symptoms in Patients With Multiple Sclerosis: A Pilot Study, The Journal of Urology, vol.184, issue.3, pp.1011-1017, 2010.
DOI : 10.1016/j.juro.2010.05.035

. Mertens, Microsurgical drezotomy for spastic limbs, Neurochirurgie, vol.49, pp.325-363, 2003.

. Moguel-ancheita, Visual neurorehabilitation of patients with cerebral damage using botulinum toxin. Cir Cir, pp.320-326, 2012.

. Mostert, Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis, Multiple Sclerosis Journal, vol.123, issue.5
DOI : 10.1212/WNL.33.11.1444

. Murthy, Botulinum toxin in the management of internuclear ophthalmoplegia, Journal of American Association for Pediatric Ophthalmology and Strabismus, vol.11, issue.5, pp.456-465, 2007.
DOI : 10.1016/j.jaapos.2007.03.005

. Newman, Tizanidine in the treatment of spasticity, European Journal of Clinical Pharmacology, vol.30, issue.Suppl 13, pp.31-36, 1982.
DOI : 10.1007/BF01061374

. Pandyan, Spasticity: Clinical perceptions, neurological realities and meaningful measurement, Disability and Rehabilitation, vol.27, issue.1-2, pp.2-6, 2005.
DOI : 10.1080/09638280400014576

. Paty, Clinical feature of multiple sclerosis. Multiple Sclerosis, pp.171-191, 1997.

. Piovesan, An open study of botulinum-A toxin treatment of trigeminal neuralgia, Neurology, vol.65, issue.8
DOI : 10.1212/01.wnl.0000180940.98815.74

. Pittock, Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population, Movement Disorders, vol.61, issue.12, pp.1482-1485, 2004.
DOI : 10.1002/mds.20227

. Pittock, A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport<sup>??</sup>) in the Treatment of Spastic Equinovarus Deformity after Stroke, Cerebrovascular Diseases, vol.15, issue.4, pp.289-300, 2003.
DOI : 10.1159/000069495

. Poulain, Le mode d'action des neurotoxines botuliques: aspects pathologiques, cellulaires et moléculaires Annales de réadaptation et de médecine physique, pp.265-273, 2003.
DOI : 10.1016/s0168-6054(03)00114-4

. Rampello, Effect of Aerobic Training on Walking Capacity and Maximal Exercise Tolerance in Patients With Multiple Sclerosis: A Randomized Crossover Controlled Study, Physical Therapy, vol.87, issue.5, pp.545-55, 2007.
DOI : 10.2522/ptj.20060085

. Repka, Treatment of Acquired Nystagmus With Botulinum Neurotoxin A, Archives of Ophthalmology, vol.112, issue.10, pp.1320-1324, 1994.
DOI : 10.1001/archopht.1994.01090220070025

. Restivo, Botulinum toxin improves dysphagia associated with multiple sclerosis, European Journal of Neurology, vol.81, issue.3
DOI : 10.1111/j.1468-1331.2010.03189.x

. Rizzo, Prevalence and treatment of spasticity reported by multiple sclerosis patients, Multiple Sclerosis Journal, vol.10, issue.5, pp.589-595, 2004.
DOI : 10.1191/1352458504ms1085oa

. Robertson, Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. Gait Posture, pp.108-120, 2009.

. Rudomin, Presynaptic inhibition in the vertebrate spinal cord revisited, Experimental Brain Research, vol.129, issue.1, pp.1-37, 1999.
DOI : 10.1007/s002210050933

. Salame, Surgical treatment of spasticity by selective posterior rhizotomy: 30 years experience, Isr Med Assoc J, vol.5, issue.8, pp.543-549, 2003.

B. Sallerin, Baclofene intrathecal: historique, preuves expérimentales et données pharmacocinétiques, Neurochirurgie, vol.49, pp.271-275, 2003.

. Santamato, Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: A case report, Journal of Rehabilitation Medicine, vol.42, issue.9
DOI : 10.2340/16501977-0596

. Schulte-baukloh, Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: An objective and subjective analysis, Neurourology and Urodynamics, vol.1, issue.2, pp.110-115, 2006.
DOI : 10.1002/nau.20153

. Sedano, Continuous Facial Myokymia in Multiple Sclerosis: Treatment with Botulinum Toxin, European Neurology, vol.43, issue.3, pp.1137-1177, 2000.
DOI : 10.1159/000008152

. Sindou, Surgery in Dorsal Root Entry Zone, pp.165-182, 1991.
DOI : 10.1007/978-3-7091-1771-2_9

. Snow, Treatment of spasticity with botulinum toxin: A double-blind study, Annals of Neurology, vol.14, issue.4, pp.512-517, 1990.
DOI : 10.1002/ana.410280407

. Stien, The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen, Acta Neurologica Scandinavica, vol.ii, issue.1, pp.190-194, 1987.
DOI : 10.1111/j.1600-0404.1987.tb07916.x

. Svensson, Costs and quality of life in multiple sclerosis patients with spasticity, Acta Neurologica Scandinavica, vol.10, issue.Suppl 2, pp.13-20
DOI : 10.1111/ane.12139

. Tarek, Botulinum Toxin in the management of hitchhiker's toe, Neurorehabilitation, vol.201128, pp.395-399

. Tok, The Effects of Onabotulinum Toxin A Injection into Rectus Femoris Muscle in Hemiplegic Stroke Patients with Stiff-Knee Gait, American Journal of Physical Medicine & Rehabilitation, vol.91, issue.4
DOI : 10.1097/PHM.0b013e3182465feb

W. Van-der, A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor, Neurology, vol.79, issue.1, pp.92-101, 2012.
DOI : 10.1212/WNL.0b013e31825dcdd9

. Vender, Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction. Neurosurg Focus, Aug, vol.1521, issue.2, 2006.
DOI : 10.3171/foc.2006.21.2.7

. Viel, Neurolytic blockade of the obturator nerve for intractable spasticity of adductor thigh muscles, European Journal of Pain, vol.30, issue.2, pp.97-104, 2002.
DOI : 10.1053/eujp.2001.0269

URL : https://hal.archives-ouvertes.fr/hal-00776009

. Viel, Alcohol neurolytic blocks for pain and muscle spasticity, Neurochirurgie, 2003.

. Viel, Peripheral neurolytic blocks and spasticity, Ann Fr Anesth Reanim, 2005.

A. Ward, A literature review of the pathophysiology and onset of post-stroke spasticity, European Journal of Neurology, vol.13, issue.Pt 5
DOI : 10.1111/j.1468-1331.2011.03448.x

. Yelnik, Poststroke hemiplegia: Lower limb benefit from botulinum toxin (review)

. Yelnik, Disabling overactivity of the extensor hallucis longus after stroke: Clinical expression and efficacy of botulinum toxin type A, Archives of Physical Medicine and Rehabilitation, vol.84, issue.1, pp.147-149, 2003.
DOI : 10.1053/apmr.2003.50077

. Yelnik, How to clinically assess and treat muscle overactivity in spastic paresis, Journal of Rehabilitation Medicine, vol.42, issue.9
DOI : 10.2340/16501977-0613